Influx Healthtech IPO GMP: Day 1 IPO Live Updates
Posted by : sachet | Wed Jun 18 2025

Influx Healthtech IPO GMP is ₹40 as of 18th June 2025. It is a bookbuilding IPO that comprises a fresh issue of 50.00 lakh shares worth ₹48.00 crores and an offer for sale of 11.00 lakh shares worth ₹10.56 crores. The issue will be listed on NSE and SME on its tentative listing date, 25th June 2025. The price band for the Influx Healthtech IPO GMP is set between ₹91 and ₹96 per share. Retail investors can bid for a minimum lot of 1,200 shares worth ₹1,15,200.
Influx Healthtech IPO GMP Grey Market Premium
As of 18th June 2025, Influx Healthtech IPO GMP stands at ₹40 per share. Thus, the estimated listing price would be ₹136 (96+40). This indicates that the estimated listing gain in this IPO could be 41.66%. However, GMP details are subject to change based on market conditions and fluctuations. Explore the table for the Influx Healthtech IPO GMP updates.
GMP Date | IPO Price | GMP | Estimated Listing Price | Estimated Listing Gains |
18-06-2025 | ₹96 | ₹40 | ₹136 | 41.66% |
17-06-2025 | ₹96 | ₹35 | ₹131 | 36.45% |
16-06-2025 | ₹96 | ₹22 | ₹118 | 22.91% |
15-06-2025 | ₹96 | ₹24 | ₹120 | 25.00% |
14-06-2025 | ₹96 | ₹0 | ₹96 | 0.00% |
13-06-2025 | ₹96 | ₹0 | ₹96 | 0.00% |
12-06-2025 | ₹96 | ₹0 | ₹96 | 0.00% |
11-06-2025 | ₹96 | ₹0 | ₹96 | 0.00% |
Influx Healthtech IPO Details
IPO Open Date | 18th June 2025 |
IPO Close Date | 20th June 2025 |
IPO Allotment Date | 23rd June 2025 |
Refund Initiation | 24th June 2025 |
Issue Size | 61,00,800 shares (worth ₹58.57 crore) |
Offer for Sale | 11,00,400 shares (worth ₹10.56 crore) |
Fresh Issue | 50,00,400 shares (worth ₹48.00 crore) |
Face Value | ₹10 per share |
Lot Size | 1,200 shares |
Issue Price Band | ₹91 to ₹96 per share |
Market Makers Portion | 3,06,000 shares |
Issue Type | Bookbuilding IPO |
Listing At | NSE & SME |
Listing Date | 25th June 2025 |
Explanation
Influx Healthtech IPO: Influx Healthtech Limited has declared a price band of ₹91 to ₹96 per share. With this IPO, the company allows retail investors to bid for at least one lot of 1,200 shares worth ₹1,15,200. The face value of Influx Healthtech Ltd.’s share is ₹10 per share. The shares of Influx Healthtech Limited will be listed on NSE & SME on its tentative listing day, 25th June 2025. Scroll down to check GMP updates and Influx Healthtech IPO reviews.
Objectives of Influx Healthtech IPO
Influx Healthtech Limited proposed to utilise the proceeds from the bookbuilding issue in the following objectives.
- To meet general corporate purposes.
- To meet working capital requirements.
- To fund the capital expenditure requirement for setting up the manufacturing facility for the Nutraceutical Division.
- Purchase of machineries for Homecare and Cosmetic Division.
Influx Healthtech IPO Registrar
The Influx Healthtech IPO is open today, on 18th June 2025, to raise ₹58.57 crore. Maashitla Securities Private Limited is the registrar of Influx Healthtech IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding Influx Healthtech IPO allotment and refund, you can contact Maashitla Securities Private Limited at investor.ipo@maashitla.com or +91-11-45121795-96.
Influx Healthtech IPO Review

The Influx Healthtech IPO has gained neutral ratings from industry experts, brokers, and institutional investors. During FY24- 25, Influx Healthtech Limited’s revenue rose 4.88% from ₹100.10 crores in March 2024 to ₹104.99 crores in March 2025. Moreover, the company’s PAT decreased by 19.16% from ₹11.22 crores to ₹13.37 crores. Investors can analyse other relevant factors and make a decision accordingly.
Most analysts recommend applying for this IPO to diversify your investment portfolio in the stock market. However, we’re waiting for further ratings to have a better idea and will keep posting them to deliver real-time insights. Until then, you can explore the company’s technical analysis to know whether you should apply for the Influx Healthtech IPO or not.
Influx Healthtech IPO Technical Analysis
Key Indicators | Value |
PE Ratio (Price-to-Earnings) | 13.04 |
EPS (Earnings Per Share) | 7.36 |
RoNW | 36.98% |
ROE (Return on Equity) | 36.98% |
ROCE | 49.17% |
PAT Margin (Profit After Tax) | 12.75 |
Market Capitalisation | ₹222.24 cr. |
The PE ratio of Influx Healthtech Limited shares is 13.04, and its Earnings Per Share (EPS) stands at 7.36. The Influx Healthtech IPO can potentially deliver gains on its tentative listing date, 25th June 2025.
Indicators | Pre-IPO | Post-IPO |
PE Ratio | 13.04 | 16.63 |
EPS | 7.36 | 5.77 |
For regular stock updates, dividend alerts, and expert verdicts, stay informed with Univest!
FAQs on Influx Healthtech IPO
What is Influx Healthtech IPO GMP?
Ans. Currently, on 18th June 2025, Influx Healthtech IPO GMP (Grey Market Premium) stands at ₹40 (41.66% up). This indicates that the estimated listing price could be ₹136 per share.
What is the issue price of Influx Healthtech IPO?
Ans. The Influx Healthtech IPO price band has been set between ₹91 and ₹96 per share. Retail investors can apply for a minimum and maximum of 1 lot consisting of 1,200 shares worth ₹1,15,200. Moreover, NIIs are required to bid for a minimum of 2 lots (2.400 shares) worth ₹2,30,400.
Who is the registrar of the Influx Healthtech IPO?
Ans. Maashitla Securities Private Limited is the registrar of Influx Healthtech IPO, awaiting to manage the IPO allotment procedure and refund initiation. For any queries regarding Influx Healthtech IPO allotment and refund, you can contact Maashitla Securities Private Limited at investor.ipo@maashitla.com or +91-11-45121795-96.
Disclaimer: The above information is compiled from authentic sources and is just for informational purposes. To have detailed information about the Influx Healthtech IPO, download the Influx Healthtech IPO RHP and Influx Healthtech IPO DRHP. Conduct your own research before investing in IPOs to avoid significant losses. You can also consult your financial advisor.
Recent Articles
Influx Healthtech IPO GMP & Review: Apply or Avoid?
Arisinfra Solutions IPO GMP & Review: Apply or Avoid?
Eppeltone Engineers IPO GMP: Day 1 IPO Live Updates
Best Battery Stocks in India to Invest in 2025 | Battery Sector Stocks
Stocks to Watch Today: 17th June 2025 | HCL Tech, Mphasis, Hyundai Motor, Mastek, Hikal, & More!
Eppeltone Engineers IPO GMP & Review: Apply or Avoid?

Related Posts
Arisinfra Solutions IPO GMP: Day 1 IPO Live Updates
Tech Stocks in India to Invest in 2025 | Tech Sector Stocks
Stock Market Today: Sensex Surged 119.45 Points & Nifty50 By 0.18%; Check Key Insights
Stocks to Watch Today: 18th June 2025 | RailTel, SRF, DCX India, Vedanta, PNB, & More!
Influx Healthtech IPO GMP & Review: Apply or Avoid?